Benzene-associated immunosuppression and chronic inflammation in humans: a systematic review

ObjectiveRecent evidence has accumulated that the immune system is intimately intertwined with cancer development. Two key characteristics of carcinogens in which the immune system plays a central role are chronic inflammation and immunosuppression. In this systematic review, we investigated the ass...

Full description

Saved in:
Bibliographic Details
Published inOccupational and environmental medicine (London, England) Vol. 78; no. 5; pp. 377 - 384
Main Authors Guo, Helen, Ahn, Stacy, Zhang, Luoping
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd 01.05.2021
BMJ Publishing Group LTD
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ObjectiveRecent evidence has accumulated that the immune system is intimately intertwined with cancer development. Two key characteristics of carcinogens in which the immune system plays a central role are chronic inflammation and immunosuppression. In this systematic review, we investigated the association of chronic inflammatory and immunosuppressive outcomes with benzene, a widely used industrial chemical. Benzene has been confirmed to cause acute myeloid leukaemia and suspected to cause non-Hodgkin lymphoma, two cancers of the blood-forming system that affect immune cells.MethodsWe systematically searched PubMed and Embase for all relevant studies using a combination of Medical Subject Headings (MeSH) and selected key words. The detailed review protocol, including search strategy, was registered with PROSPERO, the international prospective register of systematic reviews (#CRD42019138611).ResultsBased on all human studies selected in the final review, we report new evidence of a benzene-induced immunosuppressive effect on the adaptive immune system and activation of the innate immune system to cause inflammation. In particular, benzene significantly lowers the number of white blood cells, particularly lymphocytes such as CD4+ T-cells, B-cells and natural killer cells, and increases proinflammatory biomarkers at low levels of exposure.ConclusionTo the best of our knowledge, this is the first comprehensive review of benzene’s immunotoxicity in humans. Based on results obtained from this review, we propose two potential immunotoxic mechanisms of how benzene induces leukaemia/lymphoma: (1) cancer invasion caused by proinflammatory cytokine production, and (2) cancer promotion via impaired immunosurveillance. Further studies will be required to confirm the connection between benzene exposure and its effects on the immune system.
Bibliography:ObjectType-Article-1
ObjectType-Evidence Based Healthcare-3
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
Contributors LZ conceived of the original idea, initiated the study, and was principal investigator. HG was the main contributor to all phases of the study: development of the protocol and search strategy, study selection, data synthesis, table and figure creation, and the writing of the article. SA assisted in study selection, table and figure creation, and editing of the manuscript. All authors discussed the results and contributed to the final manuscript.
ISSN:1351-0711
1470-7926
1470-7926
DOI:10.1136/oemed-2020-106517